Neutralizing antibodies against SARS-CoV-2 of vaccinated healthcare workers in Taiwan
Heterologous prime-boost vaccines (AZD1222 + mRNA-1273) and two doses of mRNA vaccines are recommended. For future directions, we need to investigate the effectiveness of the vaccination against new SARS-CoV-2 variants.
Authors
- Kuang-Che Kuo (ORCID: https://orcid.org/0000-0002-3350-6724)
- Shih‐Feng Liu (ORCID: https://orcid.org/0000-0003-1394-5401)
- Ken-Pen Weng (ORCID: https://orcid.org/0000-0002-0649-1803)
- Ho‐Chang Kuo (ORCID: https://orcid.org/0000-0002-3295-2984)
- Guan‐Da Syu (ORCID: https://orcid.org/0000-0003-4661-414X)
- Seto Priyambodo (ORCID: https://orcid.org/0000-0002-9961-3143)
Institutions
- National Yang Ming Chiao Tung University (TW)
- University of Mataram (ID)
- Chang Gung University (TW)
- Kaohsiung Chang Gung Memorial Hospital (TW)
- Kaohsiung Veterans General Hospital (TW)
- National Cheng Kung University Hospital (TW)
- National Cheng Kung University (TW)
Publication Details
- Journal
- Annals of Medicine
- Published
- 2024-12-23
- DOI
- https://doi.org/10.1080/07853890.2024.2442533
- Citations
- 1
- Primary Topic
- SARS-CoV-2 and COVID-19 Research
- Type
- article
- Field-Weighted Citation Impact
- 0.39
Funders
- Ministry of Health and Welfare
- Chang Gung Memorial Hospital
- National Cheng Kung University
- National Science and Technology Council
- Hsinchu Science Park Bureau, Ministry of Science and Technology, Taiwan